CN103705909A - Drug for painless induced abortion - Google Patents
Drug for painless induced abortion Download PDFInfo
- Publication number
- CN103705909A CN103705909A CN201310686315.1A CN201310686315A CN103705909A CN 103705909 A CN103705909 A CN 103705909A CN 201310686315 A CN201310686315 A CN 201310686315A CN 103705909 A CN103705909 A CN 103705909A
- Authority
- CN
- China
- Prior art keywords
- abortion
- medication
- painless
- drug
- painless abortion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the field of drugs and in particular relates to a drug for painless induced abortion. The drug for painless induced abortion comprises ketamine and atropine. The drug for painless induced abortion is safe and is moderate in price.
Description
Technical field
The present invention relates to medicine field, be specifically related to a kind of painless abortion medication.
Background technology
At present, the painless abortion medication that hospital is used is propofol normally, propofol need to be under anaesthetist's monitoring could medication, annual because the accident that in artificial abortion's process, propofol improper use causes is not rarely seen.In addition, propofol price is higher.Urgently develop a kind of safe, moderate painless abortion medication.
Summary of the invention
For solving the problems of the technologies described above, the invention provides a kind of safe, moderate painless abortion medication.Its technical scheme is:
A painless abortion medication, described painless abortion medication comprises ketamine and atropine.
Further, described painless abortion medication also comprises diazepam.
Further, described painless abortion medication also comprises etamsylate.
Further, described painless abortion medication also comprises.
Uterine contraction element is used for shrinking uterus, and etamsylate is for hemostasis, and dexamethasone is used for shock antiallergic, its narcotic effect of ketamine, and atropine plays relieving spasm to stop pain, the effect that its positive pole of diazepam is calmed the nerves.The official regulation of consumption of various medicines, and depending on patient's concrete physical condition.
The specific embodiment
Embodiment 1
To 25 years old age, the women of body weight 50Kg before abortion, 1 of intravenous injection ketamine, 1 of atropine.Abortion is well on.
Embodiment 2
To 26 years old age, the women of body weight 55Kg before abortion, 1 of intravenous injection ketamine, 1 of atropine, 1 of diazepam.
Abortion is well on.
Embodiment 3
To 25 years old age, the women of body weight 60Kg before abortion, 1 of intravenous injection ketamine, 1 of atropine, 1 of diazepam, 1 of etamsylate.
Abortion is well on.
Embodiment 4
To 26 years old age, the women of body weight 60Kg before abortion, 1 of intravenous injection ketamine, 1 of atropine, 1 of diazepam, 1 of etamsylate, 2 of dexamethasone.Abortion carries out smoothly, and Rehabilitation is better.
Abortion is well on.
Embodiment 5
To 26 years old age, the women of body weight 60Kg before abortion, 1 of intravenous injection ketamine, 1 of atropine, 1 of diazepam, 1 of etamsylate, 2 of dexamethasone, 3 of uterine contraction elements.
Abortion is well on.
Claims (5)
1. a painless abortion medication, is characterized in that: described painless abortion medication comprises ketamine and atropine.
2. a kind of painless abortion medication according to claim 1, is characterized in that: described painless abortion medication also comprises diazepam.
3. a kind of painless abortion medication according to claim 2, is characterized in that: described painless abortion medication also comprises etamsylate.
4. a kind of painless abortion medication according to claim 3, is characterized in that: described painless abortion medication also comprises uterine contraction element.
5. a kind of painless abortion medication according to claim 4, is characterized in that: described painless abortion medication also comprises dexamethasone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310686315.1A CN103705909A (en) | 2013-12-16 | 2013-12-16 | Drug for painless induced abortion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310686315.1A CN103705909A (en) | 2013-12-16 | 2013-12-16 | Drug for painless induced abortion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103705909A true CN103705909A (en) | 2014-04-09 |
Family
ID=50399496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310686315.1A Pending CN103705909A (en) | 2013-12-16 | 2013-12-16 | Drug for painless induced abortion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103705909A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10869844B2 (en) | 2014-09-15 | 2020-12-22 | Janssen Pharmaceutica Nv | Methods for the treatment of depression |
| US11446260B2 (en) | 2013-03-15 | 2022-09-20 | Janssen Pharmaceutica Nv | Pharmaceutical composition of S-ketamine hydrochloride |
| US11707440B2 (en) | 2017-12-22 | 2023-07-25 | Janssen Pharmaceuticals, Inc. | Esketamine for the treatment of depression |
| US11883526B2 (en) | 2019-03-05 | 2024-01-30 | Janssen Pharmaceutica Nv | Esketamine for the treatment of depression |
| US11980596B2 (en) | 2017-09-13 | 2024-05-14 | Janssen Pharmaceutica Nv | Delivery of esketamine for the treatment of depression |
-
2013
- 2013-12-16 CN CN201310686315.1A patent/CN103705909A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 孙翠玲: "人工流产术中药物镇痛疗效分析", 《河南医学研究》 * |
| 李坚: "关于无痛人流手术", 《中国社区医师》 * |
| 纪宝凤: "无痛人流术应用现状", 《河北医药》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11446260B2 (en) | 2013-03-15 | 2022-09-20 | Janssen Pharmaceutica Nv | Pharmaceutical composition of S-ketamine hydrochloride |
| US10869844B2 (en) | 2014-09-15 | 2020-12-22 | Janssen Pharmaceutica Nv | Methods for the treatment of depression |
| US11173134B2 (en) | 2014-09-15 | 2021-11-16 | Janssen Pharmaceutica Nv | Methods for the treatment of depression |
| US11311500B2 (en) | 2014-09-15 | 2022-04-26 | Janssen Pharmaceutica Nv | Methods for the treatment of depression |
| US11980596B2 (en) | 2017-09-13 | 2024-05-14 | Janssen Pharmaceutica Nv | Delivery of esketamine for the treatment of depression |
| US11707440B2 (en) | 2017-12-22 | 2023-07-25 | Janssen Pharmaceuticals, Inc. | Esketamine for the treatment of depression |
| US11883526B2 (en) | 2019-03-05 | 2024-01-30 | Janssen Pharmaceutica Nv | Esketamine for the treatment of depression |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705909A (en) | Drug for painless induced abortion | |
| Zhang et al. | The effect of pre‐treatment with transcutaneous electrical acupoint stimulation on the quality of recovery after ambulatory breast surgery: a prospective, randomised controlled trial | |
| Lee et al. | Current methods of analgesia for transrectal ultrasonography (TRUS)‐guided prostate biopsy–a systematic review | |
| Sinatra | The Fentanyl HCl Patient-Controlled Transdermal System (PCTS) An Alternative to Intravenous Patient-Controlled Analgesia in the Postoperative Setting | |
| CN103933129B (en) | Plaster for treating pain | |
| CN100475249C (en) | Chinese medicinal composition for curing migraine | |
| El-Wahab et al. | Analgesia and anaesthesia in labour | |
| CN201920223U (en) | Mattress for relieving uneasiness of mind and body tranquilization | |
| CN101129677A (en) | Quick-effective pill for hemorrhoid | |
| CN103656038B (en) | A kind of Chinese medicine composition for the treatment of dysmenorrhea | |
| CN102670757A (en) | Narcotic | |
| Liu et al. | Overcoming the barriers in pain control: an update of pain management in China | |
| CN101829328A (en) | Drug for treating amphetamine-type exhilarant dependence syndrome and amphetamine-type exhilarant and opioid mixed dependence syndrome | |
| Sahin et al. | Positive effects of acupuncture on menstrual irregularity and infertility in a patient with polycystic ovary syndrome | |
| CN202951126U (en) | External-use drug permeable patch | |
| CN203015915U (en) | Magnetic therapy scarf for cervical vertebra | |
| Javot | Fentanyl withdrawal | |
| CN204484577U (en) | Stationary care device in a kind of neurosurgery | |
| CN202802530U (en) | Brain electric therapeutic cap for psychiatric department | |
| CN201005854Y (en) | Head physical cooling cap | |
| CN100464780C (en) | Hot compress medicine for treating omitis, and its preparing method | |
| CN202819710U (en) | Novel clinical shoulder pad | |
| CN101152257A (en) | Traditional Chinese medicine for treating exogenous injury | |
| CN106215096A (en) | A kind of Chinese medicine formula of cure scapulohumeral periarthritis | |
| CN202821796U (en) | Rehabilitation belt of cranial nerve |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140409 |